Wei Xia
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Cancer Research top 10%
Papers in
- Oncology 11
- Cancer Cells and Metastasis 2
- Lung Cancer Research Studies 2
- Co-authors
- Philip S. Low (6 shared papers)Ji‐Xin Cheng (1 shared paper)Eric L. Matteson (1 shared paper)Khalid Rahman (2 shared papers)Xiao Qi Wang (2 shared papers)Cheng Peng (1 shared paper)Tan To Cheung (2 shared papers)Albert Chan (2 shared papers)
- Journals
- Molecular Pharmaceutics (2 papers)Oncotarget (2 papers)Journal of Investigative Medicine (1 paper)Gene (1 paper)BioMed Research International (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wei Xia
38 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 106
- Biomaterials 210
- Cancer Research 165
- Oncology 268
- Rheumatology 133
- Molecular Biology 633
Countries citing papers authored by Wei Xia
This map shows the geographic impact of Wei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xia more than expected).
Fields of papers citing papers by Wei Xia
This network shows the impact of papers produced by Wei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xia. The network helps show where Wei Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 411 | |
| 2 | 2008 | 268 | |
| 3 | 2018 | 164 | |
| 4 | 2015 | 152 | |
| 5 | 2020 | 58 | |
| 6 | 2017 | 58 | |
| 7 | 2005 | 57 | |
| 8 | 2014 | 46 | |
| 9 | 2018 | 46 | |
| 10 | 2014 | 40 | |
| 11 | 2021 | 38 | |
| 12 | 2015 | 36 | |
| 13 | 2018 | 31 | |
| 14 | 2002 | 27 | |
| 15 | 2012 | 21 | |
| 16 | 2012 | 20 | |
| 17 | 2003 | 20 | |
| 18 | 2018 | 19 | |
| 19 | 2022 | 19 | |
| 20 | 2018 | 13 |
About Wei Xia
Wei Xia is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Surgery, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune cells in cancer (3 papers), Folate and B Vitamins Research (3 papers), Ferroptosis and cancer prognosis (3 papers), Transplantation: Methods and Outcomes (3 papers), Cancer Cells and Metastasis (2 papers), Lung Cancer Research Studies (2 papers), Macrophage Migration Inhibitory Factor (2 papers) and Inflammation biomarkers and pathways (2 papers). The work is most often cited by research in Biomaterials (210 citations), Cancer Research (165 citations), Oncology (268 citations), Rheumatology (133 citations) and Molecular Biology (633 citations). Wei Xia has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Philip S. Low, Ji‐Xin Cheng, Eric L. Matteson, Khalid Rahman, Xiao Qi Wang, Cheng Peng, Tan To Cheung, Albert Chan, Wei Yue and Yanxi Zhou. Their work appears in journals such as Molecular Pharmaceutics, Oncotarget, Journal of Investigative Medicine, Gene and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.